Meitheal Pharmaceuticals has Decitabine for Injection Now Available.
Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Decitabine for Injection, 50 mg per vial in a 20 mL single-dose vial.
Meitheal will offer Decitabine for Injection in a carton of 1 vial.
ABOUT DECITABINE FOR INJECTION
Decitabine for Injection is a nucleoside metabolic Inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoblastic in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. For full prescribing information and safety information, please click on the following link: link.
Learn more about who we are and what we do at www.meithealpharma.com.